The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma

Published:2017-05-10 Issue:XX Volume:XX Page:1-4
ISSN:2225-0719
Container-title:Journal of Clinical and Translational Hepatology
language:en
Short-container-title:

Author:

Beppu Toru,Nakagawa Shigeki,Nitta Hidetoshi,Okabe Hirohisa,Kaida Takayoshi,Imai Katsunori,Hayashi Hiromitsu,Koga Yuki,Kuramoto Kunitaka,Hashimoto Daisuke,Yamashita Yo-ichi,Chikamoto Akira,Ishiko Takatoshi,Baba Hideo

Publisher

Xia & He Publishing

Subject

Hepatology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vater Papilla-preserving Strategy for Advanced Hepatocellular Carcinoma With Excessive Bile Duct Tumor Thrombus;Anticancer Research;2022-10-26

2. Huge hepatocellular carcinoma with extrahepatic collateral arteries successfully treated by multidisciplinary treatment including laparoscopic devascularization: a case report;Clinical Journal of Gastroenterology;2020-11-12

3. Multi-parameter ultrasound based on the logistic regression model in the differential diagnosis of hepatocellular adenoma and focal nodular hyperplasia;World Journal of Gastrointestinal Oncology;2019-12-15

4. Conversion Hepatectomy for Huge Hepatocellular Carcinoma With Arterioportal Shunt After Chemoembolization and Lenvatinib Therapy;Anticancer Research;2019-09-30

5. Predicting Poorly Differentiated Hepatocellular Carcinoma that Meets the Milan Criteria;Anticancer Research;2018-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP